SEC Form 4 · accession 0001144204-15-027930
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven A Ross
Officer — CIO
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 3:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 4,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $4.78 | May 4, 2015 | A | 100,000 | A | May 4, 2016 | May 5, 2020 | Common Stock | 100,000 | 100,000 | D |
| Stock Options (Right to buy)F2 | $3.93 | holding | — | — | — | Apr 22, 2014 | Apr 22, 2019 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1On May 4, 2015 Mr. Ross was granted 100,000 stock options to purchase Common Stock of the Company. These options vest ratably on each of the first three anniversary dates from the date of grant.
- F2On April 22, 2013 Mr. Ross was granted 150,000 stock options to purchase common stock in the Company. These options vest ratably on each of the next 4 anniversary dates from the date of grant.